Yang K, Khalil M W, Strutt B J, Killinger D W
Department of Obstetrics and Gynaecology and Physiology, University of Western Ontario, Lawson Research Institute, St Joseph's Health Centre, London, Canada.
J Steroid Biochem Mol Biol. 1997 Feb;60(3-4):247-53. doi: 10.1016/s0960-0760(96)00187-2.
The biological activity of glucocorticoids in target tissues can be influenced by locally produced 11 beta-hydroxysteroid dehydrogenase (11 beta-HSD), the enzyme responsible for the interconversion of cortisol and its inactive metabolite cortisone. In human adipose stromal cells, glucocorticoids are potent stimulators of the conversion of androgens to estrogens (aromatase activity). The present study was designed to determine whether 11 beta-HSD activity was present in human adipose stromal cells, and if changes in the activity of this enzyme could influence aromatase activity. 11 beta-HSD activity was determined by a radiometric conversion assay in breast adipose tissue from six patients. It was found that both dehydrogenase (cortisol to cortisone) and reductase (cortisone to cortisol) activities were present in all six subjects, and the reductase activity was always predominant. Carbenoxolone (CBX), a potent inhibitor of 11 beta-HSD, added to the culture medium at 50 and 200 microM, resulted in 39 +/- 4% and 85 +/- 1% inhibition, respectively, of both reductase and dehydrogenase activity of 11 beta-HSD. To determine whether alterations in 11 beta-HSD could influence aromatase activity, the effect of CBX (200 microM) on cortisol- and cortisone-induced changes in the conversion of androstenedione to estrone was examined. CBX prevented the stimulatory effect of cortisone and minimally potentiated the stimulatory effect of cortisol on aromatase activity, reflecting an inhibition of the local activation of cortisone and the local metabolism of cortisol, respectively. In order to determine whether the product of the 11 beta-HSD 1 gene was responsible for the observed 11 beta-HSD activity, total RNA extracts from these cells were subjected to Northern blot analysis using human 11 beta-HSD 1 cDNA as the probe. A single 1.8 11 beta-HSD 1 transcript was detected, and its abundance was reduced by CBX. No 11 beta-HSD 2 mRNA was detected. The present results demonstrate that the 11 beta-HSD 1 gene is expressed and functional in human breast adipose stromal cells and that changes in 11 beta-HSD 1 activity result in alterations in aromatase activity.
糖皮质激素在靶组织中的生物活性可受到局部产生的11β-羟类固醇脱氢酶(11β-HSD)的影响,该酶负责皮质醇与其无活性代谢产物可的松之间的相互转化。在人脂肪基质细胞中,糖皮质激素是雄激素向雌激素转化(芳香化酶活性)的有效刺激物。本研究旨在确定人脂肪基质细胞中是否存在11β-HSD活性,以及该酶活性的变化是否会影响芳香化酶活性。通过放射性转化测定法测定了6例患者乳腺脂肪组织中的11β-HSD活性。结果发现,所有6名受试者均存在脱氢酶(皮质醇转化为可的松)和还原酶(可的松转化为皮质醇)活性,且还原酶活性始终占主导地位。将11β-HSD的强效抑制剂甘草次酸(CBX)以50和200μM添加到培养基中,分别导致11β-HSD的还原酶和脱氢酶活性受到39±4%和85±1%的抑制。为了确定11β-HSD的改变是否会影响芳香化酶活性,研究了CBX(200μM)对皮质醇和可的松诱导的雄烯二酮向雌酮转化变化的影响。CBX分别抑制了可的松的刺激作用,并最小程度地增强了皮质醇对芳香化酶活性的刺激作用,这分别反映了对可的松局部活化和皮质醇局部代谢的抑制。为了确定11β-HSD 1基因的产物是否是观察到的11β-HSD活性的原因,使用人11β-HSD 1 cDNA作为探针,对这些细胞的总RNA提取物进行了Northern印迹分析。检测到一条单一的1.8 kb 11β-HSD 1转录本,其丰度因CBX而降低。未检测到11β-HSD 2 mRNA。目前的结果表明,11β-HSD 1基因在人乳腺脂肪基质细胞中表达且具有功能,11β-HSD 1活性的变化导致芳香化酶活性改变。